Phenotype Switching and the Melanoma Microenvironment; Impact on Immunotherapy and Drug Resistance
Melanoma, a highly heterogeneous tumor, is comprised of a functionally diverse spectrum of cell phenotypes and subpopulations, including stromal cells in the tumor microenvironment (TME). Melanoma has been shown to dynamically shift between different transcriptional states or phenotypes. This is ref...
Main Authors: | Sultana Mehbuba Hossain, Michael R. Eccles |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-01-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/2/1601 |
Similar Items
-
Connecting Metabolic Rewiring With Phenotype Switching in Melanoma
by: Paola Falletta, et al.
Published: (2022-07-01) -
ROR2, a driver of “phenotype switching” in melanoma?
by: Pablo Lopez-Bergami
Published: (2022-09-01) -
Melanoma cells revive an embryonic transcriptional network to dictate phenotypic heterogeneity
by: Niels eVandamme, et al.
Published: (2014-12-01) -
Loss of CITED1, an MITF regulator, drives a phenotype switch in vitro and can predict clinical outcome in primary melanoma tumours
by: Jillian Howlin, et al.
Published: (2015-02-01) -
Low Doses of Celecoxib Might Promote Phenotype Switching in Cutaneous Melanoma Treated with Dabrafenib—Preliminary Study
by: Diana Valentina Tudor, et al.
Published: (2022-08-01)